BIOTECHNOLOGY
Editing biology like software
From cutting and pasting genes in 1973 to writing mRNA scripts that run inside your cells. A working tour of the platforms that turned living systems into engineerable substrate.
Recombinant DNA: cut, paste, run.
Stanley Cohen and Herbert Boyer used restriction enzymes as molecular scissors and plasmids as carriers, then dropped engineered DNA into E. coli — and it ran. Biology became a copy/paste medium.
Restriction enzymes
Bacterial proteins that snip DNA at specific sequences — the original "Ctrl-X."
Plasmids
Small circular DNA that copies itself inside bacteria. The first delivery vehicle.
Why it matters
Genes became portable software. Any organism could host any sequence.
A startup turns the lab trick into a company.
Boyer + venture capitalist Robert Swanson founded Genentech in South San Francisco — the first firm built explicitly to commercialize recombinant DNA. Biotech as an industry begins here.
The pitch
If bacteria can be programmed to make any protein, they can make medicines. At scale. Cheaply.
The IPO (1980)
Genentech's stock jumped from $35 to $88 in 20 minutes — Wall Street had just discovered biotech.
Human insulin, brewed in E. coli.
Before 1982, insulin was harvested from pig and cow pancreases. Genentech & Eli Lilly inserted the human insulin gene into bacteria — a fermentation tank now made identical-to-human protein. The first FDA-approved biotech drug.
Proof of concept that swept biology: you don't extract — you express.
PCR: a Xerox machine for DNA.
Polymerase Chain Reaction takes one DNA molecule and, through 30 thermal cycles, copies it a billion-fold in an afternoon. Forensics, diagnostics, COVID tests — all downstream of this trick.
Denature
95°C splits the double helix into single strands.
Anneal
~55°C lets short primers latch onto target sites.
Extend
72°C — Taq polymerase doubles the template. Repeat 30×.
230 ≈ one billion. Exponentials, applied to biology.
Sequencing collapses 100,000× in cost.
The Human Genome Project cost ~$2.7B and took 13 years. Today an Illumina NovaSeq reads a full human genome overnight for a few hundred dollars. Biology's "Moore's Law" — only steeper.
Reading became cheap before writing did. That asymmetry shaped the field for two decades — and is starting to flip.
One target. One molecule. One blockbuster.
Antibodies are Y-shaped proteins your immune system uses to grab specific molecules. Monoclonals are factory-made versions, engineered to bind a single target — and they have rewired modern medicine.
- Humira — autoimmune; once the world's top-selling drug.
- Keytruda — releases the brakes on T-cells; cancer immunotherapy.
- Herceptin, Rituxan, Ozempic-class — receptor-specific medicines.
CRISPR: programmable scissors with a GPS.
Doudna & Charpentier (2012) showed Cas9 + a guide RNA can be aimed at any 20-letter sequence in a genome. Editing went from heroic to recipe.
Guide RNA
A 20-nt address line. Change the guide, change the target.
Cas9 nuclease
Cuts both DNA strands at the chosen address.
Casgevy (2023)
First FDA-approved CRISPR therapy — sickle cell disease.
Base editing & prime editing extend the toolbox to single-letter rewrites without cutting.
mRNA platforms: ship the recipe, not the protein.
Lipid nanoparticles deliver mRNA into cells; ribosomes read the script and produce the target protein. COVID vaccines proved the platform at planetary scale — oncology vaccines and rare-disease therapies are next.
- Sequence-to-vial in weeks, not years.
- Same factory, different payload.
- Personalized cancer vaccines: tumor-specific neoantigens, made for one patient.
Synthetic biology: bacteria as fabs.
Design DNA on a screen → order it from a DNA synthesis vendor → drop it into an engineered host → it makes the molecule for you. The wet-lab equivalent of "compile and run."
Design
CAD tools, codon optimization, pathway models.
Synthesize
Print custom genes; per-base costs falling steadily.
Brew
Yeast, E. coli, mammalian cells, even cell-free systems make the product.
Examples: artemisinin (anti-malarial), spider-silk fibers, animal-free dairy proteins, leather, fragrances, fuels.
Bespoke cells. Living drugs.
Instead of a daily pill, you re-engineer the patient's own biology — once.
CAR-T
Take a patient's T-cells, equip them with a synthetic receptor, infuse them back. Some leukemias go into durable remission.
AAV vectors
Engineered viruses deliver corrected genes — Luxturna (vision), Zolgensma (SMA), Hemgenix (hemophilia B).
Bespoke n=1
Custom CRISPR therapies designed for individual children with ultra-rare mutations are now reaching patients.
In-vivo editing, organoids, generative biology.
In-vivo editing
CRISPR delivered directly into the body — no cell extraction. Early wins in liver-targeted disease (e.g., transthyretin amyloidosis).
Organoids
Mini-brains, mini-guts, mini-livers grown from stem cells — drug testing without animals; disease in a dish.
Generative biology
AI models (AlphaFold, ESM, RFdiffusion) design proteins from scratch. Antibodies, enzymes, binders — written, not discovered.
Read & watch.
Books / long reads
- Siddhartha Mukherjee — The Gene
- Walter Isaacson — The Code Breaker (Doudna & CRISPR)
- Sally Smith Hughes — Genentech: The Beginnings of Biotech
- NIH / NHGRI primers (free, current)
Watch on YouTube
Search-results links so you can pick the channel you trust.
End of deck · press ← to revisit, or click anywhere to advance.